- Trials with a EudraCT protocol (102)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
102 result(s) found for: Biobank.
Displaying page 1 of 6.
| EudraCT Number: 2021-005401-28 | Sponsor Protocol Number: AOI2021ME_PICKERING | Start Date*: 2022-01-26 |
| Sponsor Name:University Hospital of Clermont-Ferrand | ||
| Full Title: Effects of the combination of magnesium bisphosphonates versus bisphosphonates alone on bone remodeling: Randomized pilot clinical trial | ||
| Medical condition: postmenopausal osteoporosis | ||
| Disease: | ||
| Population Age: Elderly | Gender: Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005629-65 | Sponsor Protocol Number: RG_12-269 | Start Date*: 2014-01-15 | |||||||||||
| Sponsor Name:University of Birmingham | |||||||||||||
| Full Title: Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose finding study | |||||||||||||
| Medical condition: Chronic Myeloid Leukaemia (CML) in Blast Phase | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001565-37 | Sponsor Protocol Number: PrEP_COVID | Start Date*: 2020-04-03 |
| Sponsor Name:ISGlobal | ||
| Full Title: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE FOR HIGH-RISK HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC (PrEP_COVID): A UNICENTRIC, DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL. | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000130-18 | Sponsor Protocol Number: 1 | Start Date*: 2020-10-09 |
| Sponsor Name:Fundación para la Inv. Biomédica Hospital Clínico San Carlos | ||
| Full Title: Co-THEIA (Combination THerapy with mEthotrexate and adalImumAb for uveitis): Efficacy, safety and cost-effectiveness of methotrexate, adalimumab, or their combination in non infectious non anterior... | ||
| Medical condition: Non infectious non anterior uveitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002762-12 | Sponsor Protocol Number: SJ-674 | Start Date*: 2021-12-07 |
| Sponsor Name:Zealand University Hospital | ||
| Full Title: The prevalence of bile acid diarrhéa and the effect of budesonid on the bile acid homeostasis in patients with microscopic colitis | ||
| Medical condition: Microscopic colitis Bile acid diarrhea | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003816-38 | Sponsor Protocol Number: PHRC-N/2017-FJ-01 | Start Date*: 2020-11-09 | |||||||||||
| Sponsor Name:CHU DE NIMES | |||||||||||||
| Full Title: Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode | |||||||||||||
| Medical condition: Treatment of severe suicidal ideas in patients suffers from a current major depressive episode | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-002196-35 | Sponsor Protocol Number: 73520 | Start Date*: 2020-11-16 |
| Sponsor Name:Amsterdam UMC, location VUmc | ||
| Full Title: post-trial access cohort BUmetanide for Developmental DIsorders | ||
| Medical condition: Neurodevelopmental disorders Autism spectrum disorder Attention deficit hyperactivity disorder (ADHD) Learning disorders | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003665-10 | Sponsor Protocol Number: RBH2017/001 | Start Date*: 2020-02-25 | |||||||||||
| Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust | |||||||||||||
| Full Title: A single-centre study of the relationship between eosinophil activation and the lung microbiome in severe eosinophilic asthma (SEA) and the effect of benralizumab on these factors | |||||||||||||
| Medical condition: Severe Eosinophilic Asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-000397-19 | Sponsor Protocol Number: Ctrl-DM2 | Start Date*: 2014-09-09 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Effects of Combined Treatment of Surgery and Liraglutide on Glycemic Variability and Control in type 2 Diabetes Mellitus: The Ctrl-DM2 Study | ||
| Medical condition: type 2 diabetes with morbid obesity | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001960-28 | Sponsor Protocol Number: RCTVITD/SARS-CoV-19 | Start Date*: 2020-05-25 |
| Sponsor Name:Investigation Institute Bioaraba | ||
| Full Title: Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19) | ||
| Medical condition: COVID-19 infection | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-000604-25 | Sponsor Protocol Number: R96-A6604-14-S22 | Start Date*: 2015-05-02 |
| Sponsor Name:Danish Cancer Society Research Center | ||
| Full Title: HBOT LYCA: Hyperbaric Oxygen Therapy to reduce Lymphoedema after Breast Cancer - an explorative clinical trial | ||
| Medical condition: breast cancer related lymphedema | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001481-25 | Sponsor Protocol Number: BorrSciWP2 | Start Date*: 2015-09-07 |
| Sponsor Name:Sørlandet Sykehus HF | ||
| Full Title: Lyme borreliosis; a scientific approach to reduce diagnostic and therapeutic uncertainties (BorrSci) WP2; SIX VERSUS TWO WEEKS TREATMENT WITH DOXYCYCLINE IN LYME NEUROBORRELIOSIS; A MULTICENTER,... | ||
| Medical condition: Lyme Neuroborreliosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-000838-19 | Sponsor Protocol Number: N12OLG | Start Date*: 2012-06-26 | |||||||||||
| Sponsor Name:NKI-AVL | |||||||||||||
| Full Title: High-dose alkylating chemotherapy in oligo-metastatic breast cancer harboring homologous recombination deficiency | |||||||||||||
| Medical condition: Oligo metastatic breast cancer harboring homologous recombination deficiency and/or the patient has a deleterious germline BRCA1 or BRCA2 mutation | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-003012-35 | Sponsor Protocol Number: HM07/8281 | Start Date*: 2012-06-12 | |||||||||||
| Sponsor Name:Leeds Teaching Hospitals NHS Trust | |||||||||||||
| Full Title: CLARET: CLL Levels following Alemtuzumab in Responders to Early Therapy: A randomised, phase III trial to assess alemtuzumab consolidation therapy in patients with chronic lymphocytic leukaemia (CL... | |||||||||||||
| Medical condition: Chronic lymphocytic leukaemia (CLL). | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-005835-60 | Sponsor Protocol Number: APHP200038 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP) | ||
| Full Title: Induction therapy for lupus nephritis with no added oral corticosteroids : An open label randomised multicentre controlled trial comparing oral corticosteroids plus mycophenolate mofetil (MMF) ve... | ||
| Medical condition: The study population will consist of Children (14 years and above) and adults (until 75 years old) with lupus nephritis ISN/RPS class III or IV (A or A/C) ± V with active lesions in at least 10% of... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003172-32 | Sponsor Protocol Number: MASH | Start Date*: 2018-05-23 |
| Sponsor Name:Imperial College London | ||
| Full Title: Maraviroc Add-On Therapy for Steatohepatitis in HIV – The MASH Study | ||
| Medical condition: Non alcoholic steatohepatitis (NASH) in patients with HIV mono-infection | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-003733-15 | Sponsor Protocol Number: B-003 | Start Date*: 2013-11-13 |
| Sponsor Name:VU University medical center | ||
| Full Title: The Dutch CSF and PET Biomarker Concordance of Alzheimer’s Disease pathology study | ||
| Medical condition: Patients visiting the VUmc Alzheimer Center with objective cognitive complaints or diagnosed with Alzheimer's Disease. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002640-23 | Sponsor Protocol Number: APHP200003 | Start Date*: 2020-12-14 |
| Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS | ||
| Full Title: Effect of increased oxytocin doses on the mode of delivery in obese primiparous women with spontaneous labour. A double-blind, randomised, controlled trial | ||
| Medical condition: To compare the rates of caesarean section in obese patients with spontaneous labour between two oxytocin dosage regimens | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002070-31 | Sponsor Protocol Number: 1337-EASI-trial | Start Date*: 2019-09-05 |
| Sponsor Name:Copenhagen University Hospital Hvidovre | ||
| Full Title: Adherence of a 1.600 mg single tablet 5-ASA treatment of Ulcerative colitis (EASI-trial) | ||
| Medical condition: Ulcerative colitis (UC) belongs to the group of inflammatory bowel diseases. The disease course is unpredictable and characterised by chronic inflammation of the colonic mucosa, where acute attacks... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-004124-20 | Sponsor Protocol Number: 200701234 | Start Date*: 2007-10-10 | |||||||||||
| Sponsor Name:LUMC | |||||||||||||
| Full Title: Doxycycline for Stabilization of Abdominal Aortic Aneurysms | |||||||||||||
| Medical condition: Abdominal aortic aneurysm | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
